Anxiogenic-like effects of gamma-hydroxybutyric acid (GHB) in mice tested in the light-dark box

Psicothema

Volumn 20, Issue 3, 2008, Pages 460-464

  Navarro, José Francisco ^a   Dávila, Guadalupe ^a   Pedraza, Carmen ^a   Arias, Jorge L ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; OXYBATE SODIUM;

ANIMAL; ANXIETY; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIGHT; LOCOMOTION; MALE; MOUSE;

ANESTHETICS, INTRAVENOUS; ANIMALS; ANXIETY; LIGHT; LOCOMOTION; MALE; MICE; SODIUM OXYBATE;

EID: 47849086068     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barry, J.M., Costall, B., Kelly, M.E., & Naylor, R.J. (1987). Withdrawal syndrome following subchronic treatment with anxiolytic agents. Pharmacology Biochemistry and Behavior, 27, 239-245.
2. Belzung, C., Misslin, R., Vogel, E., Dodd, R.H., & Chapouthier, G. (1987). Anxiogenic effects of methyl-beta-carboline-carboxylate in a light-dark choice situation. Pharmacology Biochemistry and Behavior, 28, 29-33.
3. Crunelli, V., Emri, Z., & Leresche, N. (2006). Unravelling the brain targets of gamma-hydroxybutyric acid. Current Opinion in Pharmacology, 6, 44-52.
4. Drasbek, K.R., Christensen, J., & Jensen, K. (2006). Gammahydroxybutyrate - A drug of abuse. Acta Neurologica Scandinava, 114, 145-156.
5. García, F.B., Pedraza, C., & Navarro, J.F. (2006). Actualización del ácido gamma-hidroxibutírico (GHB). Revista de Neurología, 43, 39-48.
6. García, F.B., Pedraza, C., Arias, J.L., & Navarro, J.F. (2006). Effects of subchronic administration of gammahydroxybutyrate (GHB) on spatial working memory in rats. Psicothema, 18, 519-524.
7. Green, A.R., & McGregor, I.S. (2002). On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. Psychopharmacology, 162, 448-450.
8. Griebel, G., Misslin, J.R., Pawlowski, M., & Vogel, E. (1991). m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport, 2, 627-9.
9. Hascoët, M., & Bourin, M. (1998). A new approach to the light/dark test procedure in mice. Pharmacology Biochemistry and Behavior, 60, 645-653.
10. Hascoët, M., Bourin, M., & Dhnonnchadha, B. (2001). The mouse light-dark paradigm: a review. Progress in NeuroPsychopharmacology and Biological Psychiatry, 25, 141-166.
11. Howard, S.G., & Feigembaum, J.J. (1997). Effects of gamma-hydroxybutyrate on central dopamine release in vivo. Biochemical Pharmacology, 53, 103-110.
12. Maitre, M. (1997). The γ-hydroxybutyrate signalling system in brain: Organization and functional implications. Progress in Neurobiology, 51, 337-361.
13. Maldonado, E., & Navarro, J.F. (2000). Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box. Progress in NeuroPsychopharmacology and Biological Psychiatry, 24, 463-472.
14. Maldonado, E., & Navarro, J.F. (2001). MDMA ('Ecstasy') exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacological Research, 44, 27-31.
15. Navarro, J.F., & Maldonado, E. (1999). Behavioral profile of quinpirole in agonistic encounters between male mice. Methods and Findings in Experimental and Clinical Pharmacology, 21, 477-480.
16. Navarro, J.F., & Maldonado, E. (2002). Acute and subchronic effects of MDMA («ecstasy») on anxiety in male mice tested in the elevated plusmaze. Progress in NeuroPsychopharmacology and Biological Psychiatry, 26, 1151-1154.
17. Navarro, J.F., & Pedraza, C. (1996). An ethopharmacological assessment of the effects of gammahydroxybutyrate (GHB) on agonistic interactions in male mice. Medical Science Research, 24, 817-9.
18. Navarro, J.F., Maldonado, E., Pedraza, C., García, F., & Luna G. (2000). Gamma-hydroxybutyrate (GHB) exhibits anxiogenic-like effects in the «elevated plus maze test» in male mice. European Neuropsychopharmacology, 10 (suppl. 3), S340-1.
19. Navarro, J.F., Martín-López, M., Manzaneque, J.M., Pedraza, C., & Dávila, G. (1996). Dose-dependent effect of gamma-hydroxybutyrate (GHB) on catalepsy in male mice. Medical Science Research, 24, 603-4.
20. Navarro, J.F., Pedraza, C., Martín-López, M., Manzaneque, M., Dávila, G., & Maldonado, E. (1998). Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Progress in NeuroPsychopharmacology and Biological Psychiatry, 22, 835-844.
21. Navarro, J.F., Rivera, A., Maldonado, E., Cavas, M., & De la Calle, A. (2004). Anxiogenic-like activity of MDMA («ecstasy») in the «social interaction test» is accompanied by an increase of c-fos expression in mice amygdala. Progress in NeuroPsychopharmacology and Biological Psychiatry, 28, 249-254.
22. Olh, F. (2003). Testing for anxiety. Clinical Neuroscience Research, 3, 233-8.
23. Pedraza, C., Dávila, G., Martín-López, M., & Navarro, J.F. (2007). Anti-aggressive effects of GHB in OF1 strain mice: Involvement of dopamine D2 receptors. Progress in NeuroPsychopharmacology and Biological Psychiatry, 31, 337-342.
24. Schmidt-Mutter, C., Pain, L., Sandner, G., Gobaille, S., & Maitre, M. (1998). The anxiolytic effect of γ-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. European Journal of Pharmacology, 342, 21-27.
25. Sircar, R., & Basak, A. (2004). Adolescent γ-hydroxybutyric acid exposure decreases cortical NMDA receptor and impairs spatial learning. Pharmacology Biochemistry and Behavior, 79, 701-708.
26. Varela, M., Nogue, S., Oros, M., & Miro, O. (2004). Gamma-hydroxybutyrate use for sexual assault. Emergence Medical Journal, 21, 255-6.